Home › NDC Lookup › RxCUI directory › RxCUI 199994

Zinc acetate 25 MG Oral Capsule — RxCUI 199994

RxNorm drug concept · Semantic clinical drug
RxCUI 199994 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199994
Official nameZinc acetate 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)369 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Zinc acetate 25 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zinc acetate 25 MG Oral Capsule RxCUI 199994

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zinc acetate 58295
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Galzin 225039
    • Wilzin 2469933
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zinc acetate Oral Capsule 374335
    • Zinc acetate Oral Product 1163030
    • Zinc acetate Pill 1163031
    • Zinc acetate Oral Capsule [Galzin] 366474
    • Zinc acetate Oral Capsule [Wilzin] 2469935
    • Galzin Oral Product 1175379
    • Galzin Pill 1175380
    • Wilzin Oral Product 2469936
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Zinc acetate 25 MG 333479
    • Zinc acetate 25 MG Oral Capsule [Galzin] 213049
    • Zinc acetate 25 MG Oral Capsule [Wilzin] 2469938
    • Zinc acetate 25 MG [Galzin] 572988
    • Zinc acetate 25 MG [Wilzin] 2469934

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zinc acetate 25 MG SCDC · 333479
  • Zinc acetate Oral Capsule SCDF · 374335
  • Zinc acetate Oral Product SCDG · 1163030
  • Zinc acetate Pill SCDG · 1163031

Brand-Name Concepts

  • Zinc acetate 25 MG Oral Capsule [Galzin] SBD · 213049
  • Zinc acetate 25 MG Oral Capsule [Wilzin] SBD · 2469938
  • Zinc acetate 25 MG [Galzin] SBDC · 572988
  • Zinc acetate 25 MG [Wilzin] SBDC · 2469934
  • Zinc acetate Oral Capsule [Galzin] SBDF · 366474
  • Zinc acetate Oral Capsule [Wilzin] SBDF · 2469935
  • Galzin Oral Product SBDG · 1175379
  • Galzin Pill SBDG · 1175380
  • Wilzin Oral Product SBDG · 2469936
  • Wilzin Pill SBDG · 2469937

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 199994 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
57844-0215-52 250 CAPSULE in 1 BOTTLE (57844-215-52) GALZIN Teva Pharmaceuticals USA, Inc. 1997-03-03
71863-0124-25 250 CAPSULE, GELATIN COATED in 1 BOTTLE (71863-124-25) GALZIN Eton Pharmaceuticals, Inc. 2025-03-03
71863-0125-25 250 CAPSULE, GELATIN COATED in 1 BOTTLE (71863-125-25) GALZIN Eton Pharmaceuticals, Inc. 2025-03-03
Observed labelers: Eton Pharmaceuticals, Inc. (2) · Teva Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.